Ads
related to: schizophrenia
Search results
Schizophrenia: Finding Home on a Hard Road
MPR News· 18 hours agoSchizophrenia affects about 24 million people worldwide. People with schizophrenia require lifelong treatment, but there is hope. This program shares stories ...
'Impressive' New Data on Novel Schizophrenia Hopeful KarXT
Medscape· 5 days agoThe novel investigational antipsychotic KarXT was effective and well tolerated in adults with ...
In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using [18F]THK5351
Journal of the American Medical Association· 4 days agoThis case-control study investigates the in vivo imaging of reactive astrocytes and their association with positive symptoms in patients with schizophrenia using validated ...
Teva and Medincell’s schizophrenia drug meets main goal of late-stage study
KFGO· 5 days ago(Reuters) -Israel-based Teva Pharmaceuticals and French partner Medincell said on Wednesday their...
Colorado supermarket shooter was sane at the time of the attack, state experts say
Houston Chronicle· 6 days agoAccording to the defense, the evaluators found that the attack would not have happened but for...
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 4 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
NeuShen begins dosing for Phase I trial of schizophrenia treatment
Clinical Trials Arena via Yahoo Finance· 4 days agoNeuShen Therapeutics has dosed the first healthy volunteer in Australia, marking the start of a...
Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
Clinical Trials Arena via Yahoo Finance· 4 days agoSubcutaneous OLAnzapine Extended-Release Injection Study (SOLARIS) trial’s efficacy portion...
Teva Pharmaceutical’s stock climbs as schizophrenia treatment shows promise
Market Watch· 5 days agoTeva Pharmaceutical Industries stock jumped more than 6% early Wednesday after the company reported...
Teva stock gains on trial win, Q1 beat (NYSE:TEVA)
Seeking Alpha· 5 days agoTeva Pharmaceutical (TEVA) stock posts record gains due to better-than-expected Q1 revenue and positive Phase 3 trial results for its schizophrenia drug....
